D Trump treatment based on synthetic antibodies developed by the biotechnology company Regeneron
Donald Trump receives new treatment based on synthetic antibodies developed by the biotechnology company Regeneron
Donald Trump received a new treatment based on synthetic antibodies developed by the biotechnology company Regeneron. This treatments has given encouraging preliminary results in clinical trials on a small number of patients.
When injected into a patient's body, these synthetic antibodies attach themselves to the virus disrupting its functioning, reducing the amount of virus and accelerating recovery.
3D animation